PDCD1 and neoplasm: PD-L1 is expressed on tumor and antigen presenting cells (APCs), while its receptor PD-1 is expressed on activated T cells; this interaction suppresses T-cell activity and is associated with T-cell exhaustion (TCE), a state of depressed effector function and anergy brought on by chronic antigen exposure and hypoxia [8].